Atracurium Besylate Injection, USP is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
From the U.S. FDA-approved label for Atracurium. Full label: DailyMed.
Atracurium Besylate Injection, USP is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
From the U.S. FDA-approved label for Atracurium. Full label: DailyMed.
Atracurium besylate should be administered intravenously. DO NOT GIVE ATRACURIUM BESYLATE BY INTRAMUSCULAR ADMINISTRATION. Intramuscular administration of atracurium besylate may result in tissue irritation and there are no clinical data to support this route of administration.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Atracurium besylate is contraindicated in patients known to have a hypersensitivity to it. Use of atracurium besylate from multiple dose vials containing benzyl alcohol as a preservative is contraindicated in patients with a known hypersensitivity to benzyl alcohol.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
ATRACURIUM SHOULD BE USED ONLY BY THOSE SKILLED IN AIRWAY MANAGEMENT AND RESPIRATORY SUPPORT. EQUIPMENT AND PERSONNEL MUST BE IMMEDIATELY AVAILABLE FOR ENDOTRACHEAL INTUBATION AND SUPPORT OF VENTILATION, INCLUDING ADMINISTRATION OF POSITIVE PRESSURE OXYGEN. ADEQUACY OF RESPIRATION MUST BE ASSURED THROUGH ASSISTED OR CONTROLLED VENTILATION. ANTICHOLINESTERASE REVERSAL AGENTS SHOULD BE IMMEDIATELY AVAILABLE. DO NOT GIVE ATRACURIUM BESYLATE BY INTRAMUSCULAR ADMINISTRATION. Atracurium has no known effect on consciousness, pain threshold, or cerebration. It should be used only with adequate anesthesia.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
Observed in Controlled Clinical Studies Atracurium was well tolerated and produced few adverse reactions during extensive clinical trials. Most adverse reactions were suggestive of histamine release.
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
27 products from 15 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Acris 10mg/ml Injection | Atracurium (10mg/ml) | Gland Pharma Limited | vial of 2.5 ml Injection |
| Acris 50mg Injection | Atracurium (50mg) | Gland Pharma Limited | vial of 5 ml Injection |
| Arium 25mg/ml Injection | Atracurium (25mg/ml) | Celon Laboratories Ltd | vial of 2.5 ml Injection |
| Arium 50mg Injection | Atracurium (50mg) | Celon Laboratories Ltd | vial of 5 ml Injection |
| Artacil 100mg/ml Injection | Atracurium (100mg/ml) | Neon Laboratories Ltd | vial of 10 ml Injection |
| Artacil 10mg/ml Injection | Atracurium (10mg/ml) | Neon Laboratories Ltd | vial of 5 ml Injection |
| Artacil 50mg Injection | Atracurium (50mg) | Neon Laboratories Ltd | vial of 2.5 ml Injection |
| Atacurium 25mg/ml Injection | Atracurium (25mg/ml) | Themis Medicare Ltd | vial of 2.5 ml Injection |
| Atacurium 50mg Injection | Atracurium (50mg) | Themis Medicare Ltd | vial of 5 ml Injection |
| Atb 25mg/ml Injection | Atracurium (25mg/ml) | Cachet Pharmaceuticals Pvt Ltd | vial of 2.5 ml Injection |
| Atb 50mg Injection | Atracurium (50mg) | Cachet Pharmaceuticals Pvt Ltd | vial of 2 ml Injection |
| Atcurium 25mg Injection | Atracurium (25mg/2.5ml) | Chandra Bhagat Pharma Pvt Ltd | ampoule of 5 injections |
| Atrabloc 10mg Injection | Atracurium (10mg) | Varenyam Healthcare Pvt Ltd | vial of 10 ml Injection |
| Atrabloc 25 Injection | Atracurium (25mg) | Varenyam Healthcare Pvt Ltd | ampoule of 2.5 ml Injection |
| Atrabloc Injection | Atracurium (10mg) | Varenyam Healthcare Pvt Ltd | ampoule of 5 ml Injection |
| Atracade 25mg/ml Injection | Atracurium (25mg/ml) | Bharat Serums & Vaccines Ltd | vial of 1 ml Injection |
| Atracurium Besilate Injection | Atracurium (NA) | Sun Pharmaceutical Industries Ltd | vial of 1 ml Injection |
| Atrager 25mg/ml Injection | Atracurium (25mg/ml) | Zydus Cadila | vial of 1 ml Injection |
| Atrager 50mg Injection | Atracurium (50mg) | Zydus Cadila | vial of 5 ml Injection |
| Atrapure 100mg/ml Injection | Atracurium (100mg/ml) | Samarth Life Sciences Pvt Ltd | vial of 10 ml Injection |
| Atrapure 25mg/ml Injection | Atracurium (25mg/ml) | Samarth Life Sciences Pvt Ltd | vial of 1 Injection |
| Atrapure 50mg Injection | Atracurium (50mg) | Samarth Life Sciences Pvt Ltd | vial of 5 ml Injection |
| Atrelax 10mg/ml Injection | Atracurium (10mg/ml) | Raman Weil Pvt Ltd | vial of 1 ml Injection |
| Crimat 25mg/ml Injection | Atracurium (25mg/ml) | Miracalus Pharma Pvt Ltd | vial of 2.5 ml Injection |
| Kabitran Injection | Atracurium (10mg/ml) | Fresenius Kabi India Pvt Ltd | ampoule of 2.5 ml Injection |
| Troycurium Injection | Atracurium (10mg/ml) | Troikaa Pharmaceuticals Ltd | vial of 2.5 ml Injection |
| Troycurium Injection 2.5ml | Atracurium (25mg/ml) | Troikaa Pharmaceuticals Ltd | packet of 5 injections |
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Storage Atracurium Besylate Injection should be refrigerated at 2° to 8°C (36° to 46°F) to preserve potency. Storage conditions (25°C/77°F), use Atracurium Besylate Injection within 14 days even if re-refrigerated. Protect from light.
Storage information from the U.S. FDA-approved label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.
